Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists test how body weight influences a new drug's absorption

NCT ID NCT07673601

Recruiting now Knowledge-focused Sponsor: argenx Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests a drug called adimanebart in healthy adults to see how much of it gets into the bloodstream and how body weight affects that process. Participants receive a single dose either by IV or as an injection under the skin. Researchers will measure drug levels over time and check for side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
adimanebart
What this could lead to
Results could help determine the best dose and injection method for future studies of adimanebart in patients.
What could go wrong
This is an early-phase study in healthy volunteers, not patients, so findings may not predict effects in people with the target disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEER HEALTHY VOLUNTEERS (HV)

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Altasciences

    RECRUITING

    Montreal, H3P 3P1, Canada

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.